This site is intended for Healthcare Professionals only

Lexon UK

well-pharmacy-summary

Well makes £13m loss as it exits dozens of ‘non-core’ branches

'A challenging year for the business' say directors as latest Well accounts published

26 Mar 2025 , 1 Min Article

notes-and-coins-summary

‘Material errors’: Drug firms overturn £35m collusion fines on appeal

Drug companies win appeal against the CMA's findings on prochlorperazine market entry.

28 May 2024 , 3 Min Article

acquisition-summary

Competition watchdog poised to approve Well’s acquisition of 46 pharmacies

Multiple has found buyers for seven existing branches to address takeover concerns

27 Jul 2023 , 1 Min Article

acquisition-summary

Well Pharmacy seeks to pacify watchdog by axing seven stores

CMA has 'reasonable grounds' to believe Bestway's divestment offer will be acceptable.

23 Jun 2023 , 1 Min Article

New Project(17).jpg

Bestway purchase of Lexon raises competition concerns, says CMA

Proposals have been submitted to offload pharmacies following CMA investigation.

15 Jun 2023 , 2 Min Article

mceu_1068538611681732458777.jpg

BREAKING: Well Pharmacy acquires wholesalers Lexon and Asurex

Bestway said it will notify the Competition and Markets Authority about the deal.

17 Apr 2023 , 1 Min Article

Disqualified 1280.jpg

CMA disqualifies former Lexon director over illegal information sharing

Watchdog disqualifies Pritesh Sonpal from taking up a director's role in Britain for four years.

12 Jan 2022 , 1 Min Article

money summary.jpg

Medicines wholesaler secures multi-million refinancing deal

Lexon secures multi million asset-based lending facility with HSBC.

05 Jan 2022 , 1 Min Article

money notes cash finance financial profit summary.jpg

Lexon's appeal against £1.2m fine for collusion dismissed

The Competition Appeal Tribunal has dismissed pharmaceutical company Lexon’s appeal against a £1.2m fine for breaking competition law. 

25 Feb 2021 , 1 Min Article

money notes cash finance financial profit.jpg

Lexon appeals against £1.2m nortriptyline fine

CMA says it will defend an appeal brought by Lexon against a £1.2m fine for allegedly sharing commercially sensitive information.

02 Jun 2020 , 1 Min Article

drug-tablet-pill-medicine-CMA-collusion-summary.jpg

Four companies fined £3.4m in CMA nortriptyline probe

Wholesaler Lexon (UK) has been fined although it denies any infringement.

04 Mar 2020 , 1 Min Article

Change privacy settings